Syndecan-4 negatively regulates antiviral signalling by mediating RIG-I deubiquitination via CYLD

Nature Communications

Volumn 7, Issue , 2016, Pages

  Lin, Wei ^a   Zhang, Jing ^a   Lin, Haiyan ^a   Li, Zexing ^a   Sun, Xiaofeng ^a   Xin, Di ^a   Yang, Meng ^a   Sun, Liwei ^a   Li, Lin ^a   Wang, Hongmei ^a   Chen, Dahua ^a   Sun, Qinmiao ^a  

^a INSTITUTE OF ZOOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEUBIQUITINASE; DEUBIQUITINASE CYLD; RETINOIC ACID INDUCIBLE PROTEIN I; SYNDECAN 4; UNCLASSIFIED DRUG; CYLD PROTEIN, MOUSE; CYSTEINE PROTEINASE; MEMBRANE PROTEIN; NERVE PROTEIN; ROBO3 PROTEIN, MOUSE; SDC4 PROTEIN, MOUSE;

BIOASSAY; GENETIC ANALYSIS; INFECTIVITY; PATHOGEN; RECOGNITION; RODENT; VIRUS; YEAST;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DEUBIQUITINATION; FEEDBACK SYSTEM; FEMALE; HEK293 CELL LINE; HELA CELL LINE; HOMEOSTASIS; HOST CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; GENETICS; INNATE IMMUNITY; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

MUS;

ANIMALS; CYSTEINE ENDOPEPTIDASES; IMMUNITY, INNATE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; SYNDECAN-4; UBIQUITINATION;

EID: 84973661450     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11848     Document Type: Article

References (39)

1. Janeway, Jr. C. A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol. 54, 1-13 (1989).
2. Kawai, T. & Akira, S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
3. Takeuchi, O. & Akira, S. MDA5/RIG-I and virus recognition. Curr. Opin. Immunol. 20, 17-22 (2008).
4. Yoneyama, M., Onomoto, K., Jogi, M., Akaboshi, T. & Fujita, T. Viral RNA detection by RIG-I-like receptors. Curr. Opin. Immunol. 32, 48-53 (2015).
5. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
6. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
7. Seth, R. B., Sun, L., Ea, C. K. & Chen, Z. J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122, 669-682 (2005).
8. Meylan, E. et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172 (2005).
9. Xu, L. G. et al. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19, 727-740 (2005).
10. Kawai, T. et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6, 981-988 (2005).
11. Oshiumi, H., Matsumoto, M., Hatakeyama, S. & Seya, T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J. Biol. Chem. 284, 807-817 (2009).
12. Arimoto, K. et al. Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl Acad. Sci. USA 104, 7500-7505 (2007).
13. Friedman, C. S. et al. The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep. 9, 930-936 (2008).
14. Fan, Y. et al. USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J. Exp. Med. 211, 313-328 (2014).
15. Wang, L. et al. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J. Virol. 87, 4507-4515 (2013).
16. Liu, H. M. et al. The mitochondrial targeting chaperone 14-3-3e regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host. Microbe. 11, 528-537 (2012).
17. Tkachenko, E., Rhodes, J. M. & Simons, M. Syndecans: new kids on the signaling block. Circ. Res. 96, 488-500 (2005).
18. Echtermeyer, F. et al. Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat. Med. 15, 1072-1076 (2009).
19. Liu, W. et al. Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J. Biol. Chem. 273, 22825-22832 (1998).
20. Gao, Y., Li, M., Chen, W. & Simons, M. Synectin, syndecan-4 cytoplasmic domain binding PDZ protein, inhibits cell migration. J. Cell Physiol. 184, 373-379 (2000).
21. Polte, T. et al. Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation. Nat. Commun. 6, 7554 (2015).
22. Endo, T. et al. Syndecan 4 regulation of the development of autoimmune arthritis in mice by modulating B cell migration and germinal center formation. Arthritis Rheumatol. 67, 2512-2522 (2015).
23. Beauvais, D. M., Ell, B. J., McWhorter, A. R. & Rapraeger, A. C. Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 206, 691-705 (2009).
24. Lim, S. T., Longley, R. L., Couchman, J. R. & Woods, A. Direct binding of syndecan-4 cytoplasmic domain to the catalytic domain of protein kinase C alpha (PKC alpha) increases focal adhesion localization of PKC alpha. J. Biol. Chem. 278, 13795-13802 (2003).
25. Corti, F., Finetti, F., Ziche, M. & Simons, M. The syndecan-4/protein kinase Calpha pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo. J. Biol. Chem. 288, 12712-12721 (2013).
26. Shi, Q., Jiang, J. & Luo, G. Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J. Virol. 87, 6866-6875 (2013).
27. Lefevre, M., Felmlee, D. J., Parnot, M., Baumert, T. F. & Schuster, C. Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particleassociated apolipoprotein E. PLoS ONE 9, e95550 (2014).
28. Horowitz, A. & Simons, M. Phosphorylation of the cytoplasmic tail of syndecan-4 regulates activation of protein kinase Calpha. J. Biol. Chem. 273, 25548-25551 (1998).
29. Oh, E. S., Woods, A. & Couchman, J. R. Syndecan-4 proteoglycan regulates the distribution and activity of protein kinase C. J. Biol. Chem. 272, 8133-8136 (1997).
30. Takeuchi, O. & Akira, S. Pattern recognition receptors and inflammation. Cell 140, 805-820 (2010).
31. Okuyama, E. et al. Molecular mechanisms of syndecan-4 upregulation by TNFalpha in the endothelium-like EAhy926 cells. J. Biochem. 154, 41-50 (2013).
32. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
33. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
34. Lin, R. et al. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281, 2095-2103 (2006).
35. Tanino, Y. et al. Syndecan-4 regulates early neutrophil migration and pulmonary inflammation in response to lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 47, 196-202 (2012).
36. Na, K. Y., Bacchini, P., Bertoni, F., Kim, Y. W. & Park, Y. K. Syndecan-4 and fibronectin in osteosarcoma. Pathology 44, 325-330 (2012).
37. Li, Z. et al. PPM1A regulates antiviral signaling by antagonizing TBK1-mediated STING phosphorylation and aggregation. PLoS Pathog. 11, e1004783 (2015).
38. Zhao, Y. et al. COX5B regulates MAVS-mediated antiviral signaling through interaction with ATG5 and repressing ROS production. PLoS Pathog. 8, e1003086 (2012).
39. Zhong, B. et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550 (2008).